BioTech Innovation and National Security Continuation Act

Bill: 118-hr-9900
Sponsor: full_name: Rep. Khanna, Ro [D-CA-17]
Introduced: 2024-10-01
Policy area: Armed Forces and National Security
Latest action: action_date: 2024-10-01
text: Referred to the House Committee on Armed Services.

Summaries:

tv_txt: I 118th CONGRESS 2d Session H. R. 9900 IN THE HOUSE OF REPRESENTATIVES October 1, 2024 Mr. Khanna introduced the following bill; which was referred to the Committee on Armed Services A BILL To modify the National Security Commission on Emergency Biotechnology.

1. Short title This Act may be cited as the BioTech Innovation and National Security Continuation Act . 2. Modification of National Security Commission on Emerging Biotechnology Section 1091 of the National Defense Authorization Act for Fiscal Year 2022 ( Public Law 117–81 ) is amended— (1) in subsection (b)(3) by striking the authority to make such appointment or appointments shall expire, and the number of members of the Commission shall be reduced by the number equal to the number of appointments so not made and inserting such appointments shall nevertheless be considered valid ; (2) in subsection (g)(1), by inserting and 6 months after 3 years ; and (3) in subsection (r), by striking 18 months after the date on which it submits the final report required by subsection (g) and inserting on December 31, 2026 .